PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

NCT06696742 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bladder (Urothelial, Transitional Cell) Cancer

Interventions

DRUG: Clostridium Butyricum Tablets
DRUG: Cisplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University